24/7

8000177 +201210937777

Australia, Qatar & Egypt

24/7

8000177 +201210937777

Australia, Qatar & Egypt

24/7

8000177 +201210937777

Australia, Qatar & Egypt

How to get COVID-19 Vaccine?

How to get COVID-19 Vaccine?

Is there a vaccine for covid 19 ??

Yes there are now several vaccines that are in use. The first mass vaccination programme started in early December 2020 and as of and as of 15 February 2021, 175.3 million vaccine doses have been administered. At least 7 different vaccines (3 platforms) have been administered.

WHO issued an Emergency Use Listing (EULs) for the Pfizer COVID-19 vaccine (BNT162b2) on 31 December 2020. On 15 February 2021, WHO issued EULs for two versions of the AstraZeneca/Oxford COVID-19 vaccine, manufactured by the Serum Institute of India and SKBio. WHO is on track to EUL other vaccine products through June.

Will covid 19 vaccine provide long term immunity ?

Because COVID vaccines have only been developed in the past months, it’s too early to know the duration of protection of COVID-19 vaccines. Research is ongoing to answer this question. However, it’s encouraging that available data suggest that most people who recover from COVID-19 develop an immune response that provides at least some period of protection against reinfection – although we’re still learning how strong this protection is, and how long it lasts.

How quickly could covid 19 vaccines stop the pandemic ?

 The impact of COVID-19 vaccines on the pandemic will depend on several factors. These include the effectiveness of the vaccines; how quickly they are approved, manufactured, and delivered; the possible development of other variants and how many people get vaccinated

Whilst trials have shown several COVID-19 vaccines to have high levels of efficacy, like all other vaccines, COVID-19 vaccines will not be 100% effective. WHO is working to help ensure that approved vaccines are as effective as possible, so they can have the greatest impact on the pandemic.

What types of covid vaccines are being developed ?

Several different types of potential vaccines for COVID-19 are in development, including:

  1. Inactivated or weakened virus vaccines, which use a form of the virus that has been inactivated or weakened so it doesn’t cause disease, but still generates an immune response.
  2. Protein-based vaccines, which use harmless fragments of proteins or protein shells that mimic the COVID-19 virus to safely generate an immune response.
  3. Viral vector vaccines, which use a safe virus that cannot cause disease but serves as a platform to produce coronavirus proteins to generate an immune response.
  4. RNA and DNA vaccines, a cutting-edge approach that uses genetically engineered RNA or DNA to generate a protein that itself safely prompts an immune response.

   What are the benefits of being vaccinated ?

 Developing immunity through vaccination means there is a reduced risk of developing the  illness and its consequences. This immunity helps you fight the virus if exposed. Getting vaccinated may also protect people around you, because if you are protected from getting infected and from disease, you are less likely to infect someone else. This is particularly important to protect people at increased risk for severe illness from COVID-19, such as healthcare providers, older or elderly adults, and people with other medical conditions.

How will we know if covid 19 vaccines are safe ?

The process to develop COVID vaccines is fast-tracked while maintaining the highest standards: Given the urgent need to stop the pandemic, pauses between steps, often needed to secure funding, have been shortened, or eliminated, and in some cases, steps are being carried out in parallel to accelerate the process, wherever that is safe to do. COVID-19 vaccine developers have issued a joint pledge not to seek government approval for their vaccines until they’ve been proven to be safe and effective. 

There are many strict protections in place to help ensure that COVID-19 vaccines are safe. Like all vaccines, COVID-19 vaccines are going through a rigorous, multi-stage testing process, including large (phase III) trials that involve tens of thousands of people. These trials, which include some groups at high risk for COVID-19 (certain groups like pregnant and lactating women were not included in vaccine trials), are specifically designed to identify any common side effects or other safety concerns.